Meng Su
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Extracellular vesicles in disease
- Circular RNAs in diseases
- Advanced biosensing and bioanalysis techniques
- RNA modifications and cancer
- DNA and Nucleic Acid Chemistry
Papers in
- Oncology 19
- Colorectal Cancer Surgical Treatments 4
Meng Su
69 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 491
- Molecular Biology 1.1k
- Oncology 318
- Immunology 149
- Pulmonary and Respiratory Medicine 203
Countries citing papers authored by Meng Su
This map shows the geographic impact of Meng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Su more than expected).
Fields of papers citing papers by Meng Su
This network shows the impact of papers produced by Meng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Su. The network helps show where Meng Su may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meng Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 10 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 4 | |
| 6 | 2021 | 21 | |
| 7 | 2019 | 7 | |
| 8 | 2018 | 4 | |
| 9 | 2018 | 20 | |
| 10 | 2018 | 7 | |
| 11 | Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non–Small Cell Lung Cancer Using Next-Generation Sequencing Hit paper breakdown → | 2017 | 437 |
| 12 | 2017 | 42 | |
| 13 | 2017 | 29 | |
| 14 | 2015 | 12 | |
| 15 | 2014 | 18 | |
| 16 | 2014 | 6 | |
| 17 | Fermi Bubbles: A 10 Kpc Shock From The Galactic Center? | 2011 | 1 |
| 18 | 2010 | 52 | |
| 19 | 2009 | 38 | |
| 20 | 2004 | 79 |
About Meng Su
Meng Su is a scholar working on Oncology, Cancer Research, Molecular Biology, Biotechnology and Pulmonary and Respiratory Medicine, having authored 74 papers that have together received 1.8k indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (7 papers), Advanced biosensing and bioanalysis techniques (7 papers), RNA modifications and cancer (7 papers), RNA and protein synthesis mechanisms (6 papers), Colorectal Cancer Surgical Treatments (4 papers), Colorectal and Anal Carcinomas (4 papers), Nanoplatforms for cancer theranostics (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Cancer Research (491 citations), Molecular Biology (1.1k citations), Oncology (318 citations), Immunology (149 citations) and Pulmonary and Respiratory Medicine (203 citations). Meng Su has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Congying Xie, Lihao Zhao, Huafang Su, Xiance Jin, Baochai Lin, Deyao Xie, Thomas Carell, Xiaona Cai, Didi Chen and Linger Liu. Their work appears in journals such as Journal of the American Chemical Society, Journal of Cancer, Photodiagnosis and Photodynamic Therapy, Molecular Cytogenetics and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.